Tirzepatide Injectable
Dual GIP/GLP-1 receptor agonist prescribed for weight management
$249.00
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for weight management alongside diet and lifestyle changes, with dosing individualized by your provider.
What this treatment does
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is prescribed for weight management alongside diet and lifestyle changes, with dosing individualized by your provider.
- Supports weight management alongside diet and lifestyle changes
- Dual-action: targets both GIP and GLP-1 receptors
- Acts on two appetite-related receptor pathways
- Once-weekly injection
- Ongoing provider monitoring and dose titration
From intake to doorstep
- 01
Complete a brief online health assessment
- 02
Provider review within 24 hours
- 03
Compounded medication shipped to your door
- 04
Ongoing dose titration and monthly check-ins
Frequently asked
Tirzepatide acts on two receptors (GIP and GLP-1); semaglutide acts on one (GLP-1). Your provider will discuss which may be appropriate for you.
What patients say
No reviews yet.
Verified patient reviews will appear here once collected.
